APICMO Experienced PHD Team Focuses on Research and Development

APICMO Experienced PHD Team Focuses on Research and Development

Posted: Updated:

Specializing in key intermediates for new research and development in the medical industry, APICMO.com is proud to highlight the work of their professional PHD team

Yangpu District, Shanghai,China – August 30, 2018 /MarketersMedia/

APICMO, is a leading pharmaceutical company that takes pride in its PHD team experience in dealing with Merck, Lilly, and several other pharmaceutical companies. The company has a focus on research and development of cancer/tumor-targeted drug intermediates (API). Along with that, they are known to have mass production for CMO and CDMO orders.

The specialization of the company is in key intermediates related to new research and development in the field of oncology. It provides system development, mass production, synthetic customization, and several other services for a number of drug research and development institutions as well as pharmaceutical companies.

Among the products that APICMO offers include chemical and biologically derived pharmaceutical intermediates, fines, and APIs. The advantage of the company regarding drug research and development is in the advance of quality control, chemicals, marketing, project management, and cGMP manufacturing. All of which improves the company’s reach to other companies.

The pharmaceutical company can deliver the highest quality cancer key API thanks to its strong R&D team comprised of experienced scientists lead by Dr. Zeng Zhaosen. Furthermore, a large-scale production plant and business development management team supports the company. Besides, its APICMO team management has exceptional members.

The team management of APICMO includes members mostly from developed countries, including Japan, the United States, and Europe. They are cdmo and CMO professionals with more than enough knowledge and experience in this field. Moreover, APIMO has over ten years of industry experience dealing with multinational pharmaceutical companies.

“With more than a decade of market accumulation, clients of APICMO can rest assured that the company has a strong and broad base of cooperation in the industry of pharmaceutical intermediates,” stated company spokesperson Dr. Zeng. “The company’s vast array of products and services, as well as loyal clients, is more than enough evidence. Among the products that the company offer includes Heterocycles, Pyrimidines, Pyridines, Azetidines, Chiral compounds and other compounds.”

Additional information about the services provided by APICMO can be found by visiting the company’s website.

ABOUT APICMO

APICMO is a pharmaceutical company specializing in key intermediates for new research and development of oncology, providing system development, synthetic customization, mass production and other services for drug research and development institutions and

APICMO has a strong R&D team and experienced scientists. It has a large-scale production plant and business development management team. The APICMO team management members are mostly from developed countries such as the United States, Europe, and Japan. More than 10 years of industry experience in multinational pharmaceutical companies. After more than ten years of market accumulation, apicmo has a broad base of cooperation in the pharmaceutical intermediates industry.

Contact Info:
Name: DR.zeng
Email: info@apicmo.com
Organization: apicmo Biochemical Technology Co.,ltd
Address: Building D, 2 floor, No. 128, Xiangyin Road, Yangpu District, 200433, Shanghai, China
Phone: +8617620456565

Source URL: https://marketersmedia.com/apicmo-experienced-phd-team-focuses-on-research-and-development/400450

For more information, please visit https://www.apicmo.com

Source: MarketersMedia

Release ID: 400450

Information contained on this page is provided by an independent third-party content provider. Frankly and this Station make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com

  • NEWSMore>>

  • Channel Seeds: Staying Connected

    Channel Seeds: Staying Connected

    Thursday, October 18 2018 11:39 AM EDT2018-10-18 15:39:14 GMT
    Channel Seeds: Seedsmanship RoadshowChannel Seeds: Seedsmanship Roadshow
    Channel Seeds: Seedsmanship RoadshowChannel Seeds: Seedsmanship Roadshow

    Channel seedsmen know the importance of staying connected to deliver customized service all season long.

    Channel seedsmen know the importance of staying connected to deliver customized service all season long.

  • Wyffels Field Focus: Partners in Success

    Wyffels Field Focus: Partners in Success

    Tuesday, October 16 2018 2:09 PM EDT2018-10-16 18:09:49 GMT
    Wyffels Hybrids - Production Manager Jacob WyffelsWyffels Hybrids - Production Manager Jacob Wyffels

    Careful control over processes and procedures underly success – for the company and for its customers.

    Careful control over processes and procedures underly success – for the company and for its customers.

  • AARP Live Minute: Protecting Personal Info

    AARP Live Minute: Protecting Personal Info

    Thursday, October 11 2018 3:02 PM EDT2018-10-11 19:02:23 GMT
    AARP Live Minute: Protecting Your Personal InfoAARP Live Minute: Protecting Your Personal Info

    Test your knowledge of the latest lingo and techniques employed by scammers.

    Test your knowledge of the latest lingo and techniques employed by scammers.

Powered by Frankly
All content © Copyright 2000 - 2018 Frankly and RFDTV. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service , and Ad Choices .